We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+3.39%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$661M
AUM Growth
-$473M
Cap. Flow
-$486M
Cap. Flow %
-73.58%
Top 10 Hldgs %
6.77%
Holding
1,175
New
248
Increased
83
Reduced
484
Closed
358

Top Buys

Rank Stock Value
1
CPNG icon
Coupang
CPNG
+$3.58M
2
AZO icon
AutoZone
AZO
+$3.03M
3
HWM icon
Howmet Aerospace
HWM
+$2.87M
4
ANSS
Ansys
ANSS
+$2.84M
5
IT icon
Gartner
IT
+$2.66M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.61M
2
GM icon
General Motors
GM
+$6.29M
3
BG icon
Bunge Global
BG
+$5.38M
4
QCOM icon
Qualcomm
QCOM
+$5M
5
USFD icon
US Foods
USFD
+$4.97M

Sector Composition

Rank Sector Weight
1 Technology 21.14%
2 Healthcare 20.5%
3 Financials 14.07%
4 Industrials 12.62%
5 Consumer Discretionary 11.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UVV icon
551
Universal Corp
UVV
$1.37B
$334K 0.05%
+7,244
New +$379K
TWKS
552
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
$334K 0.05%
31,864
-41,300
-56% -$582K
CBU icon
553
Community Bank
CBU
$3.39B
$333K 0.05%
+5,539
New +$365K
ARKO icon
554
ARKO Corp
ARKO
$868M
$332K 0.05%
35,339
-29,153
-45% -$277K
PHR icon
555
Phreesia
PHR
$689M
$330K 0.05%
+12,957
New +$323K
BJ icon
556
BJs Wholesale Club
BJ
$12.8B
$329K 0.05%
+4,518
New +$324K
GENI icon
557
Genius Sports
GENI
$1.95B
$329K 0.05%
89,556
-86,127
-49% -$310K
PBH icon
558
Prestige Consumer Healthcare
PBH
$2.47B
$329K 0.05%
+6,610
New +$366K
WING icon
559
Wingstop
WING
$3.8B
$329K 0.05%
2,621
-15,242
-85% -$1.82M
NVTA
560
DELISTED
Invitae Corporation
NVTA
$328K 0.05%
+133,155
New +$404K
NAVI icon
561
Navient
NAVI
$819M
$325K 0.05%
22,100
+5,713
+35% +$87.2K
SANM icon
562
Sanmina
SANM
$8.78B
$323K 0.05%
7,006
-2,013
-22% -$93.8K
TOWN icon
563
Towne Bank
TOWN
$3.54B
$323K 0.05%
+12,027
New +$345K
XPO icon
564
XPO
XPO
$23.4B
$322K 0.05%
12,173
-7,385
-38% -$230K
PBF icon
565
PBF Energy
PBF
$7.49B
$319K 0.05%
9,064
-23,347
-72% -$740K
FOLD
566
DELISTED
Amicus Therapeutics
FOLD
$318K 0.05%
+30,505
New +$340K
WDFC icon
567
WD-40
WDFC
$2.98B
$318K 0.05%
+1,807
New +$337K
ESPR
568
DELISTED
Esperion Therapeutics
ESPR
$316K 0.05%
47,138
-90,735
-66% -$623K
DECK icon
569
Deckers Outdoor
DECK
$14.1B
$315K 0.05%
+6,048
New +$315K
SBSI icon
570
Southside Bancshares
SBSI
$963M
$315K 0.05%
+8,906
New +$342K
TRMB icon
571
Trimble
TRMB
$13.6B
$315K 0.05%
+5,800
New +$367K
BIIB icon
572
Biogen
BIIB
$30.9B
$314K 0.05%
+1,175
New +$250K
DOMO icon
573
Domo
DOMO
$171M
$314K 0.05%
17,436
-9,259
-35% -$243K
GPC icon
574
Genuine Parts
GPC
$17.9B
$314K 0.05%
+2,100
New +$317K
CROX icon
575
Crocs
CROX
$6.63B
$313K 0.05%
4,556
-5,313
-54% -$369K

Similar funds

PDT Partners's Q3 2022 Portfolio in Review

As of Q3 2022, PDT Partners held 1,175 positions worth $661M, down 42% from $1.13B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

PDT Partners withdrew a net $486M in Q3 2022, closing 358 positions and reducing 484 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $7.61M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, PDT Partners opened a new position in Coupang worth $3.45M.

  • PDT Partners's largest Q3 2022 buy was Coupang: 207,142 shares worth $3.45M.
  • PDT Partners added most to AutoZone in Q3 2022, an estimated $3.03M increase.
  • PDT Partners's biggest Q3 2022 reduction was General Motors, cutting an estimated $6.29M.
  • PDT Partners fully exited Vertex Pharmaceuticals in Q3 2022, selling an estimated $7.61M.
  • PDT Partners's ten largest holdings make up 6.8% of its $661M portfolio in Q3 2022.
  • PDT Partners opened 248 new positions and closed 358 in Q3 2022.
  • PDT Partners's portfolio value fell 42% quarter-over-quarter to $661M.

Based on PDT Partners's 13F filing for Q3 2022, filed 14 Nov 2022.